← Back to Search

Motor Control Evaluation for Parkinson's Disease

N/A

Recruiting

Led By Hyosub Kim, PhD

Research Sponsored by University of Delaware

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to perform reaching movements of ~20 cm (8 inches)

Age 18-85 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during intervention

Awards & highlights

Study Summary

This trial is testing how well people with Parkinson's can control their reaching movements in different environments.

Who is the study for?

This trial is for people aged 18-85 with Parkinson's Disease who can make reaching movements and are on Parkinson's medication. They must have a good level of mental function (MMSE score ≥ 26/30) and be able to attend all test sessions.Check my eligibility

What is being tested?

The study focuses on understanding motor control in Parkinson's patients by observing their responses to changes while they reach for things in virtual reality.See study design

What are the potential side effects?

Since the intervention involves assessment rather than medication, there are no direct side effects from drugs; however, participants may experience fatigue or discomfort from the VR environment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can reach out about 8 inches.

Select...

I am between 18 and 85 years old.

Select...

I have been diagnosed with Parkinson's disease.

Select...

I am currently on medication that affects dopamine levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and during intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

End-point errors

Movement times

Reaction times

Trial Design

1Treatment groups

Experimental Treatment

Group I: Behavioral testingExperimental Treatment1 Intervention

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,697 Previous Clinical Trials

6,952,714 Total Patients Enrolled

University of DelawareLead Sponsor

154 Previous Clinical Trials

25,111 Total Patients Enrolled

Hyosub Kim, PhDPrincipal InvestigatorUniversity of Delaware

Media Library

motor control assessment Clinical Trial Eligibility Overview. Trial Name: NCT04616508 — N/A

Parkinson's Disease Research Study Groups: Behavioral testing

Parkinson's Disease Clinical Trial 2023: motor control assessment Highlights & Side Effects. Trial Name: NCT04616508 — N/A

motor control assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04616508 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open to participants aged 25 and above in this clinical trial?

"In line with the requirements for participation, patients must be at least 18 years old yet not exceed 85 in order to qualify."

Answered by AI

Has this research project opened its doors to new participants?

"Indeed, the clinicaltrials.gov website reveals that this research is currently recruiting participants. The trial was first posted on December 12th 2018 and recently updated on October 30 2020; the study aims to enroll a total of 100 patients from one medical centre."

Answered by AI

How many study participants are included in this research?

"Indeed, according to information on clinicaltrials.gov, the study which was initially posted on December 12th 2018 is actively recruiting volunteers. Approximately 100 patients are needed across one medical centre."

Answered by AI

Who meets the criteria for participating in this investigation?

"The trial is currently seeking 100 individuals who are 18-85 years old, have been self-diagnosed with Parkinson's disease, possess a minimum MMSE score of 26/30 and perform reaching movements of 8 inches in length or more. Furthermore, potential participants must be taking dopaminergic or dopamine agonist medication and willing to attend all testing sessions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Online Motor Control in People With Parkinson's Disease

2018. "Online Motor Control in People With Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04616508.

All > Parkinsons Disease > Parkinson Disease